electroCore, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ECOR research report →
About the company
electroCore, Inc. is a commercial-phase medical device enterprise whose focus lies in developing and bringing to market a variety of non-invasive vagus nerve stimulation (nVNS) therapies. Currently, the firm is advancing gammaCore, a prescription-only nVNS therapy specifically engineered for adults to acutely treat the discomfort associated with both migraine and episodic cluster headaches.
- CEO
- Thomas J. Errico
- IPO
- 2018
- Employees
- 73
- HQ
- Rockaway, NJ, US
Price Chart
- Market Cap
- $72.75M
- P/E
- -4.85
- P/S
- 2.08
- P/B
- -13.80
- EV/EBITDA
- -5.83
- Div Yield
- 0.00%
- Gross Margin
- 87.25%
- Op Margin
- -41.97%
- Net Margin
- -44.08%
- ROE
- 836.32%
- ROIC
- -379.10%
- Revenue
- $32.03M · 27.20%
- Net Income
- $-13,966,000 · -17.50%
- EPS
- $-1.65 · -3.77%
- Op Income
- $-13,153,000
- FCF YoY
- -18.78%
- 52W High
- $10.49
- 52W Low
- $4.16
- 50D MA
- $7.77
- 200D MA
- $6.23
- Beta
- 0.87
- Avg Volume
- 105.07K
Get TickerSpark's AI analysis on ECOR
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 28, 26 | Lev Joshua S. | sell | 6,667 |
| May 21, 26 | Errico Thomas J. | buy | 9,992 |
| May 20, 26 | Errico Thomas J. | other | 8 |
| May 22, 26 | Lev Joshua S. | sell | 3,000 |
| Apr 13, 26 | Fox Michael | other | 70,000 |
| Apr 10, 26 | Goldberger Daniel S | sell | 16,072 |
| Apr 13, 26 | Fox Michael | other | 0 |
| Apr 1, 26 | Lev Joshua S. | other | 45,000 |
| Mar 19, 26 | Errico Thomas J. | other | 19,252 |
| Mar 19, 26 | Errico Thomas J. | other | 22,803 |
Our ECOR coverage
Recent articles, reports, and earnings notes.
No research on ECOR yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate ECOR report →Similar companies
Peers in the same neighborhood.